NASDAQ:CDXC
ChromaDex Corporation Stock News
$3.44
+0.0500 (+1.47%)
At Close: Apr 26, 2024
ChromaDex Corp. (NASDAQ:CDXC) today announced the results of several new studies, which have uncovered new clinical and preclinical findings for its Niagen® (nicotinamide riboside, or NR) cellular nu
ChromaDex to Report First Quarter 2020 Financial Results on Monday, May 11, 2020
10:32am, Friday, 01'st May 2020
ChromaDex Corp. (NASDAQ:CDXC) announced that it will hold a conference call on Mon., May 11, 2020 at 4:30 p.m. ET to discuss its financial results for the first quarter ended Mar. 31, 2020. The financ
ChromaDex Corp. (NASDAQ:CDXC) announced today the expansion of its partnership with A.S. Watson Group into Europe and launch of its flagship Tru Niagen® cellular health product online and in over 200
We're Hopeful That ChromaDex (NASDAQ:CDXC) Will Use Its Cash Wisely
10:47am, Monday, 27'th Apr 2020
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...
Chromadex (CDXC) Receives a Buy from H.C. Wainwright
11:14am, Friday, 24'th Apr 2020
In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Chromadex (CDXC), with a price target of $6.00. The company's
Chromadex (CDXC) Receives a Buy from H.C. Wainwright
11:14am, Friday, 24'th Apr 2020
In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Chromadex (CDXC – Research Report),
Stocks That Hit 52-Week Highs On Thursday
02:41pm, Thursday, 23'rd Apr 2020
During Thursday's morning trading, these companies set new 52-week highs.Noteworthy Points: * Johnson & Johnson (NYSE: JNJ) was the largest company by market cap to set a new 52-week high. * The sm
Analysts Offer Insights on Conglomerates Companies: Chromadex (CDXC) and Energy Recovery (ERII)
11:50am, Thursday, 23'rd Apr 2020
There's a lot to be optimistic about in the Conglomerates sector as 2 analysts just weighed in on Chromadex (CDXC) and Energy Recovery (ERII) with bullish
ChromaDex and Watsons Launch New Tru Niagen® Beauty Cellular Nutrient in Hong Kong, Broadening Global Retail Partnership
10:32am, Thursday, 23'rd Apr 2020
ChromaDex Corp. (NASDAQ:CDXC) announced today the exclusive launch of its new Tru Niagen® Beauty cellular health and beauty daily supplement with Watsons Hong Kong, available online and in all Watson
Chromadex (NASDAQ:CDXC) Earns "Buy" Rating from Oppenheimer
08:56am, Tuesday, 21'st Apr 2020
Chromadex (NASDAQ:CDXC)‘s stock had its “buy” rating reaffirmed by analysts at Oppenheimer in a research report issued on Tuesday, AnalystRatings.com reports. They currently have a $6.00 price t
Chromadex (CDXC) Receives a Buy from Oppenheimer
04:51am, Tuesday, 21'st Apr 2020
Oppenheimer analyst Brian Nagel maintained a Buy rating on Chromadex (CDXC) today and set a price target of $6.00. The company's shares closed last Monday
ChromaDex Corp. (NASDAQ:CDXC), a global scientific authority on nicotinamide adenine dinucleotide (NAD) and innovators behind Niagen® (patented nicotinamide riboside) science, announced today the pub
Analysts Offer Insights on Consumer Goods Companies: Roku (ROKU) and Chromadex (CDXC)
12:13pm, Tuesday, 14'th Apr 2020
Companies in the Consumer Goods sector have received a lot of coverage today as analysts weigh in on Roku (ROKU) and Chromadex (CDXC). Roku (ROKU) In a
Analysts Offer Insights on Consumer Goods Companies: Roku (NASDAQ: ROKU) and Chromadex (NASDAQ: CDXC)
12:13pm, Tuesday, 14'th Apr 2020
Companies in the Consumer Goods sector have received a lot of coverage today as analysts weigh in on Roku (ROKU
Elysium Health, Inc. Loses Appeal of Patent Challenge Decision, Upholding Validity of ChromaDex Intellectual Property
10:32am, Tuesday, 14'th Apr 2020
ChromaDex Corp. (NASDAQ:CDXC) issued the following statement:
